US Stock MarketDetailed Quotes

NLSP NLS Pharmaceutics

Watchlist
  • 0.1386
  • -0.0013-0.93%
Close May 8 16:00 ET
  • 0.1323
  • -0.0063-4.55%
Post 17:54 ET
6.01MMarket Cap-277P/E (TTM)

NLS Pharmaceutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

NLS Pharmaceutics Earnings Date

Currency: USD

Period

H1 FY2023 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.20

+62.96%
Analyst Rating

No Data

NLS Pharmaceutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2023/H10.000 / 0.000--
--2022/H20.000 / 0.000--
--2022/H10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2023/H10.000 / 0.000--
--2022/H20.000 / 0.000--
--2022/H10.000 / 0.000--

NLS Pharmaceutics Earnings Reports

  • NLS Pharmaceutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Apr 15 16:05 ET

  • NLS Pharmaceutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Mar 21 17:18 ET

  • NLS Pharmaceutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Mar 14 09:03 ET

  • NLS Pharmaceutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Dec 6, 2023 16:44 ET

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg